New Tumor Suppressor Genes in Hot Spots of Human Chromosome 3: New Methods of Identification

Molecular Biology

Volumn 37, Issue 2, 2003, Pages 170-185

  Braga, E A ^a   Kashuba, V I ^b,c   Malyukova, A V ^a,b   Loginov, V I ^a   Senchenko, V N ^b   Bazov, I V ^a,b   Kisselev, L L ^d   Zabarovsky, E R ^b,d  

^a STATE RESEARCH INSTITUTE OF GENETICS AND SELECTION OF INDUSTRIAL MICROORGANISMS   (Russian Federation)

^b KAROLINSKA INSTITUTE   (Sweden)

^c INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

^d ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

Author keywords

Chromosome 3 short arm (3p); Epithelial tumors; Extrachromosomal vectors; Functional testing; Human; Methylation; Real time polymerase chain reaction; Suppressor genes

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; BLASTICIDIN; BRCA1 PROTEIN; HYALURONIDASE; HYGROMYCIN; PROTEIN; SEMAPHORIN; TETRACYCLINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANGIOGENESIS; ANTIBIOTIC RESISTANCE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE; CHROMOSOME 3; CHROMOSOME 3P; COMPARATIVE GENOMIC HYBRIDIZATION; CPG ISLAND; CYTOGENETICS; DNA MICROARRAY; EXON; EXTRACHROMOSOMAL VECTOR SYSTEM; FLUORESCENCE IN SITU HYBRIDIZATION; FUNCTIONAL GENE INACTIVATION TEST; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE INACTIVATION; GENE MAPPING; GENE MUTATION; GENE SEQUENCE; GENE SILENCING; GENE THERAPY; GENE VECTOR; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GENOME; GENOMICS; HETEROZYGOSITY LOSS; HUMAN; HYBRIDIZATION; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; METHYLATION; MISSENSE MUTATION; NONHUMAN; PROMOTER REGION; PROTEIN FUNCTION; REGULATORY MECHANISM; TECHNIQUE; TUMOR; TUMOR CELL LINE; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

EID: 0037278419     PISSN: 00268933     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023381218481     Document Type: Article

References (103)

1. Zochbauer-Muller S., Gazdar A.F., Minna J.D. 2002. Molecular pathogenesis of lung cancer. Annu. Rev. Physiol. 64, 681-708.
2. Kiselev, F.L. 1998. DNA stabilization genes and carcinogenesis. Mol. Biol. 32, 197-205.
3. Evan G.I., Vousden K.H. 2001. Proliferation, cell cycle and apoptosis in cancer. Nature. 411, 342-348.
4. Ponder B.A.J. 2001. Cancer genetics. Nature. 411, 336-341.
5. Baranova A.V. and Yankovskii N.K. 1998. Tumor suppressor genes. Mol. Biol. 32, 206-218.
6. Tomlinson I.P.M., Novelli M.R., Bodmer W.F. 1996. The mutation rate and cancer. Proc. Natl. Acad. Sci. USA. 93, 14800-14803.
7. Macleod K. 2000. Tumor suppressor genes. Current Opin. Genet. Devel. 10, 81-93.
8. Kok K., Naylor S.L., Buys C.H.C.M. 1997. Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. Adv. Cancer Res. 71, 27-92.
9. Mertens F., Johansson B., Hoeglund M., Mitelman F. 1997. Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. Cancer Res. 57, 2765-2780.
10. Erlandsson R. 1998. Molecular genetics of renal cell carcinoma. Cancer Genet. Cytogenet. 104, 1-18.
11. Lindblad-Toh K., Tanenbaum D.M., Daly M.J., Winchester E., Liu W.-O., Villapakkam A., Stanton S.E., Larsson C., Hudson T.J., Johnson B.E., Lander E.S., Meyerson M. 2000. Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays. Nature Biotechnol. 18, 1001-1005.
12. Alimov A., Kost-Alimova M., Liu J., Li C., Bergerheim U., Imreh S., Klein G., Zabarovsky E.R. 2000. Combined LOH/CGH analysis proves the existence of interstitial 3p deletions in renal cell carcinoma. Oncogene. 19, 1392-1399.
13. Gray J.W., Collins C. 2000. Genome changes and gene expression in human solid tumors. Carcinogenesis. 21, 443-452.
14. Lash A.E., Tolstoshev C.M., Wagner L., Schuler G.D., Strausberg R.L., Riggins G.J., Altschul S.F. 2000. SAGEmap: a public gene expression resource. Genome Res. 10, 1051-1060.
15. Dreijerink K., Braga E., Kuzmin I., Geil L., Duh F.M., Angeloni D., Zbar B., Lerman M.I., Stanbridge E.J., Minna J.D., Protopopov A., Li J., Kashuba V., Klein G., Zabarovsky E.R. 2001. The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proc. Natl. Acad. Sci. USA. 98, 7504-7509.
16. Diatchenko L., Lukyanov S., Lau Y.F., Siebert P.D. 1999. Suppression subtractive hybridization: a versatile method for identifying differentially expressed genes. Methods Enzymol. 303, 349-380.
17. Lisitsyn N.A., Lisitsina N.M., Dalbagni G., Barker P., Sanchez C.A., Gnarra J., Linehan W.M., Reid B.J., Wigler M.H. 1995. Comparative genomic analysis of tumors: detection of DNA losses and amplification. Proc. Natl. Acad. Sci. USA. 92, 151-155.
18. Li J., Wang F., Zabarovska V., Wahlestedt C., Zabarovsky E.R. 2000. COP - a new procedure for cloning and enrichment of single nucleotide polymorphisms. Nucleic Acids Res. 28, e1.
19. Zabarovska V., Li J., Muravenko O., Fedorova L., Bra-ga E., Ernberg I., Wahlestedt C., Klein G., Zabarovsky E. R. 2000. CIS-cloning of identical sequences between two complex genomes. Chromosome Res. 8, 77-84.
20. Li J., Wang F., Kashuba V., Wahlestedt C., Zabarovsky E.R. 2001. Cloning of deleted sequences (CODE): A genomic subtraction method for enriching and cloning deleted sequences. Biotechniques. 31, 788-793.
21. Zabarovsky E.P. 2000. New strategies for cloning identical or differing DNA fragments from complex genomes. Mol. Biol. 34, 612-625.
22. Brazma A., Hingamp P., Quackenbush J., Sherlock G., Spellman P., Stoeckert C., Aach J., Ansorge W., Ball C.A., Causton H.C., Gaasterland T., Glenisson P., Holstege F.C., Kim I.F., Markowitz V., Matese J.C., Parkinson H., Robinson A., Sarkans U., Schulze-Kremer S., Stewart J., Taylor R., Vilo J., Vingron M. 2001. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nature Genet. 29, 365-371.
23. Li J., Protopopov A., Wang F., Senchenko V., Petushkov V., Vorontsova O., Petrenko L., Zabarovska V., Muravenko O., Braga E., Kisselev L., Lerman M.I., Kashuba V., Klein G., Ernberg I., Wahlestedt C., Zabarovsky E.R. 2002. NotI subtraction and NotI-specific microarrays to detect copy number and methylation changes in whole genomes. Proc. Natl. Acad. Sci. USA. 99, 10724-10729.
24. Kashuba V.I., Gizatullin R.Z., Protopopov A.I., Li J., Vorobieva N.V., Fedorova L., Zabarovska V.I., Muravenko O.V., Kost-Alimova M., Domninsky D.A., Kiss C., Allikmets R., Zakharyev V.M., Braga E.A., Sumegi J., Lerman M., Wahlestedt C., Zelenin A.V., Sheer D., Winberg G., Grafodatsky A., Kisselev L.L., Klein G., Zabarovsky E.R. 1999. Analysis of NotI linking clones isolated from human chromosome 3 specific libraries. Gene. 239, 259-271.
25. Zabarovsky E.R. 2002. Chromosomal jumping. in Encyclopedia of Molecular Medicine. Ed Creighton T.E. NY: John Wiley & Sons, Inc. 2, 832-835.
26. Zabarovsky E.R. 2002. Linking libraries. in Encyclopedia of Molecular Medicine. Ed Creighton T.E. NY: John Wiley & Sons, Inc. 3, 1933-1935.
27. Zabarovsky E.R. 2002. Jumping libraries. in Encyclopedia of Molecular Medicine. Ed Creighton T.E. NY: John Wiley & Sons, Inc. 3, 1839-1841.
28. Sugimura T., Ushijima T. 2000. Genetic and epigenetic alterations in carcinogenesis. Mutat. Res. 462, 235-246.
29. Galm O., Rountree M.R., Bachman K.E., Jair K.W., Baylin S.B., Herman J.G. 2002. Enzymatic regional methylation assay: a novel method to quantify regional CpG methylation density. Genome Res. 12, 153-157.
30. Li J., Protopopov A.I., Gizatullin R.Z., Kiss C., Kashuba V.I., Winberg G., Klein G., Zabarovsky E.R. 1999. Identification of new tumor suppressor genes based on in vivo functional inactivation of a candidate gene. FEBS Lett. 451, 289-294.
31. Protopopov A.I., Li J., Winberg G., Gizatullin R.Z., Kashuba V.I., Klein G., Zabarovsky E.R. 2002. Human cell lines engineered for tetracycline- regulated expression of tumor suppressor candidate genes from a frequently affected chromosomal region, 3p21. J. Gene Med. 4, 397-406.
32. Kuzmin I., Gillespie J.W., Protopopov A., Geil L., Dreijerink K., Yang Y., Vocke C.D., Duh F.M., Zabarovsky E., Minna J.D., Rhim J.S., Emmert-Buck M.R., Linehan W.M., Lerman M.I. 2002. The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells. Cancer Res. 62, 3498-3502.
33. Wang Z., Engler P., Longacre A., Storb U. 2001. An efficient method for high-fidelity BAC/PAC retrofitting with a selectable marker for mammalian cell transfection. Genome Res. 11, 137-142.
34. Mullins L.J., Kotelevtseva N., Boyd A.C., Mullins J.J. 1997. Efficient Cre-lox linearisation of BACs: applications to physical mapping and generation of transgenic animals. Nucleic Acids Res. 25, 2539-2540.
35. Stanbridge E.J. 1990. Human tumor suppressor genes. Annu. Rev. Genet. 24, 615-657.
36. Cheng Y., Poulos N.E., Lung M.L., Hampton G., Ou B., Lerman M.I., Stanbridge E.J. 1998. Functional evidence for a nasopharyngeal carcinoma tumor suppressor gene that maps at chromosome 3p21.3. Proc. Natl. Acad. Sci. USA. 95, 3042-3047.
37. Lowell M., Lott S.T., Wong P., El-Naggar A., Tucker S., Killary A.M. 1999. The genetic locus NRC-1 within chromosome 3p12 mediates tumor suppression in renal cell carcinoma independently of histological type, tumor microenvironment, and VHL mutation. Cancer Res. 59, 2182-2189.
38. Imreh S., Kost-Alimova M., Kholodnyuk I., Yang Y., Szeles A., Kiss H., Liu Y., Foster K., Zabarovsky E.R., Stanbridge E.J., Klein G. 1997. Differential elimination of 3p and retention of 3q segments in human/mouse microcell hybrids during tumor growth. Genes Chrom. Cancer. 20, 224-233.
39. Szeles A., Yang Y., Sandlund A., Kholodnyuk I., Kiss H., Kost-Alimova M., Zabarovsky E.R., Stanbridge E., Klein G., Imreh S. 1997. Human/mouse microcell hybrid based elimination test reduces the putative tumor suppressor region at 3p21.3 to 1.6 cM. Genes Chromos. Cancer. 20, 329-336.
40. Yang Y., Kost-Alimova M., Ingvarsson S., Qianhui Q., Kiss H., Szeles A., Kholodnyuk I., Cuthbert A., Klein G., Imreh S. 2001. Similar regions of human chromosome 3 are eliminated from or retained in human/human and human/mouse microcell hybrids during tumor growth in severe combined immunodeficient (SCID) mice. Proc. Natl. Acad. Sci. USA. 98, 1136-1141.
41. Kholodnyuk I., Kost-Alimova M., Yang Y., Kiss H., Fedorova L., Klein G., Imreh S. 2002. The microcell hybrid-based "elimination test" identifies a 1-Mb putative tumor-suppressor region at 3p22.2-p22.1 centromeric to the homozygous deletion region detected in lung cancer. Genes Chrom. Cancer. 34, 341-344.
42. Wang L., Darling J., Zhang J-S., Liu W., Qian J., Bostwick D., Hartmann L., Jenkins R., Bardenhauer W., Shutte J., Opalka B., Smith D.I. 2000. Loss of expression of the DRR1 gene at chromosomal segment 3p21.1 in renal cell carcinoma. Genes Chrom. Cancer. 27, 1-10.
43. Wistuba I.I., Behrens C., Virmani A.K., Mele G., Milchgrub S., Girard L., Fondon J.W. 3rd, Garner H.R., McKay B., Latif F., Lerman M.I., Lam S., Gazdar A.F., Minna J.D. 2000. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res. 60, 1949-1960.
44. Braga E., Senchenko V., Bazov I., Loginov W., Ermilova V., Kazubskaya T., Garkavtseva R., Mazurenko N., Kisseljov F., Liu J., Lerman M.I., Kisselev L., Klein G., Zabarovsky E. 2002. Critical tumor-suppressor gene regions on chromosome 3p in major human epithelial malignancies: allelotyping and quantitative real-time PCR. Int. J. Cancer. 100, 543-541.
45. Braga E., Pugacheva E., Bazov I., Ermilova V., Kazubskaya T., Mazurenko N., Kisseljov F., Liu J., Garkavtseva R., Zabarovsky E., Kisselev L. 1999. Comparative allelotyping of the short arm of human chromosome 3 in epithelial tumors of four different types. FEBS Lett. 454, 215-219.
46. Fullwood P., Marchini S., Rader J.S., Martinez A., Macartney D., Broggini M., Morelli C., Barbanti-Brodano G., Maher E.R., Latif F. 1999. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer. Cancer Res. 59, 4662-4667.
47. Maitra A., Wistuba I.I., Wachington C., Virmani A.K., Ashfaq R., Milchgrub S., Gazdar A.F., Minna J.D. 2001. High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss. Am. J. Pathol. 159, 119-130.
48. Sekine M., Nagata H., Tsuji S., Hirai Y., Fujimoto S., Hatae M., Kobayashi I., Fujii T., Nagata I., Ushijima K., Obata K., Suzuki M., Yoshinaga M., Umesaki N., Satoh S., Enomoto T., Motoyama S., Tanaka K., The Japanese Familial Ovarian Cancer Study Group 2001. Localization of a novel susceptibility gene for familial ovarian cancer to chromosome 3p22-p25. Human Molec. Genet. 10, 1421-1429.
49. Martinez A., Walker R.A., Shaw J.A., Dearing S.J., Maher E.R., Latif F. 2001. Chromosome 3p allele loss in early invasive breast cancer: detailed mapping and association with clinicopathological features. J. Clin. Pathol.: Mol. Pathol. 54, 300-306.
50. Liu J., Zabarovska V., Braga E., Alimov A., Klein G., Zabarovsky E.R. 1999. Loss of heterozygosity in tumor cells requires re-evaluation: the data are biased by the size-dependent differential sensitivity of allele detection. FEBS Lett. 462, 121-128.
51. Senchenko V., Liu J., Braga E., Mazurenko N., Loginov W., Seryogin Y., Bazov I., Kisseljov F., Kashuba V., Lerman M.I., Klein G., Zabarovsky E. 2003. Deletion mapping of cervical carcinomas using quantitative real-time PCR identifies two frequently affected regions in 3p21.3. Oncogene. 22 (in press).
52. Boulay J-L., Reuter J., Ristchard R., Terracciano L., Herrmann R., Rochlist C. 1999. Gene dosage quantitative real-time PCR. BioTechniques. 27, 228-232.
53. Ginzinger D.G., Godfrey T.E., Nigro J., Moore D.H. II, Suzuki S., Pallavicini M.G., Gray J.W., Jensen R.H. 2000. Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis. Cancer Res. 60, 5405-5409.
54. Hu L.-F., Eiriksdottir G., Lebedeva T., Kholodnyuk I., Alimov A., Chen F., Luo Y., Zabarovsky E.R., Ingvarsson S., Klein G., Ernberg I. 1996. Allelic deletion on chromosome 3 in primary nasopharyngeal carcinoma. Genes Chrom. Cancer. 17, 118-126.
55. Wei M-H., Latif F., Bader F., Kashuba V., Chen J-J., Duh F-M., Sekido Y., Lee C-C., Geil L., Kuzmin I., Zabarovsky E., Klein G., Zbar B., Minna J.D., Lerman M.I. 1996. Construction of a 600-kilobase cosmid clone contig and generation of a transcriptional map surrounding the lung cancer tumor suppressor gene (TSG) locus on human chromosome 3p21.3: progress toward the isolation of a lung cancer TSG. Cancer Res. 56, 1487-1492.
56. Sekido Y., Ahmadian M., Wistuba I.I., Latif F., Bader S., Wei M.H., Duh F.M., Gazdar A.F., Lerman M.I., Minna J.D. 1998. Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene. Oncogene. 16, 3151-3157.
57. Murata Y., Tamari M., Takahashi T., Horio Y., Hibi K., Yokoyama S,. Inazawa J., Yamakawa K., Ogawa A., Takahashi T., Nakamura Y. 1994. Characterization of an 800 kb region at 3p22-p21.3 that was homozygously deleted in a lung cancer cell line. Human Molec. Genet. 3, 1341-1344.
58. Kashuba V.I., Szeles A., Allikmets R., Bergenheim U., Modi W., Grafodatsky A., Dean M., Stanbridge E.J., Winberg G., Klein G., Zabarovsky E.R. 1995. A group of NotI jumping and linking clones cover 2.5 Mb in the 3p21-p22 region suspected to contain a tumor suppressor gene. Cancer Genet. Cytogenet. 81, 144-150.
59. Ishikawa S., Kai M., Tamari M., Takei Y., Takeuchi K., Bandou H., Yamane Y., Ogawa M., Nakamura Y. 1997. Sequence analysis of a 685-kb genomic region on chromosome 3p22-p21.3 that is homozygously deleted in a lung carcinoma cell line. DNA Res. 4, 35-43.
60. Jensen D.E., Proctor M., Marquis S.T., Gardner H.P., Ha S.I., Chodosh L.A., Ishov A.M., Tommerup N., Vissing H., Sekido Y., Minna J., Borodovsky A., Schultz B.C., Wilkinson K.D., Maul G.G., Barlev N., Berger S.L., Prendergast G.C., Rauscher F.J. 1998. BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene. 16, 1097-1112.
61. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Lerman M.I., Minna J.D. 2000. The 630-kb Lung Cancer Homozygous Deletion Region on Human Chromosome 3p21.3: Identification and Evaluation of the Resident Candidate Tumor Suppressor Genes. Cancer Res. 60, 6116-6133.
62. Zabarovsky E.R., Lerman M.I., Minna J. 2002. Tumor Suppressor Genes on Chromosome 3p Involved in the Pathogenesis of Lung and Other Cancers. Oncogene. 21, 6915-6935.
63. Yamato T., Orikasa K., Fukushige S., Orikasa S., Horii A. 1999. Isolation and characterization of the novel gene, TU3A, in a commonly deleted region on 3p14.3-p14.2 in renal cell carcinoma. Cytogenet Cell Genet. 87, 291-295.
64. Gao B., Sekido Y., Maximov A., Saad M., Forgacs E., Latif F., Wei M.H., Lerman M., Lee J.H., Perez-Reyes E., Bezprozvanny I., Minna J.D. 2000. Functional properties of a new voltage-dependent calcium channel alpha(2)delta auxiliary subunit gene (CACNA2D2). J. Biol. Chem. 275, 12237-12242.
65. Vavvas D., Li X., Avruch J., Zhang X.F. 1998. Identification of Norel as a potential Ras effector. J. Biol. Chem. 273, 5439-5442.
66. Kim S.T., Lim D.S., Canman C.E., Kastan M.B. 1999. Substrate specificities and identification of putative substrates of ATM kinase family members. J. Biol. Chem. 274, 37538-37543.
67. Dammann R., Li C., Yoon J.H., Chin P.L., Bates S., Pfeifer G.P. 2000. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nature Genet. 25, 315-319.
68. Burbee D.G., Forgacs E., Zochbauer-Muller S., Shivakumar L., Fong K., Gao B., Randle D., Kondo M., Virmani A., Bader S., Sekido Y., Latif F., Milchgrub S., Toyooka S., Gazdar A.F., Lerman M.I., Zabarovsky E., White M., Minna J.D. 2001. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J. Natl. Cancer Inst. 93, 691-699.
69. Dammann R., Yang G., Pfeifer G.P. 2001. Hypermethylation of the CpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. Cancer Res. 61, 3105-3109.
70. Shivakumar L., Minna J.D., Sakamaki T., Pestell R.G., White M.A. 2002. The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol. Cell. Biol. 22, 4309-4318.
71. Vos M.D., Ellis C.A., Bell A., Birrer M.J., Clark G.J. 2000. Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. J. Biol. Chem. 275, 35669-35672.
72. Kondo M., Ji L., Kamibayashi C., Tomizawa Y., Randle D., Sekido Y., Yokota J., Kashuba V., Zabarovsky E., Kuzmin I., Lerman M., Roth J., Minna J.D. 2001. Overexpression of candidate tumor suppressor gene FUS1 isolated from the 3p21.3 homozygous deletion region leads to G1 arrest and growth inhibition of lung cancer cells. Oncogene. 20, 6258-6262.
73. Triggs-Raine B., Salo T.J., Zhang H., Wicklow B.A., Natowicz M.R. 1999. Mutations in HYAL1, a member of a tandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, mucopolysaccharidosis IX. Proc. Natl. Acad. Sci. USA. 96, 6296-6300.
74. Frost G.I., Mohapatra G., Wong T.M., Csoka A.B., Gray J.W., Stern R. 2000. HYAL1LUCA-1, a candidate tumor suppressor gene on chromosome 3p21.3, is inactivated in head and neck squamous cell carcinomas by aberrant splicing of pre-mRNA. Oncogene. 19, 870-877.
75. Zhang L., Underhill C.B., Chen L. 1995. Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res. 55, 428-433.
76. Csoka A.B., Frost G.I., Stern R. 2001. The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol. 20, 499-508.
77. Sekido Y., Bader S., Latif F., Chen J.Y., Duh F.M., Wei M.H., Albanesi J.P., Lee C.C., Lerman M.I., Minna J.D. 1996. Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns. Proc. Natl. Acad. Sci. USA. 93, 4120-4125.
78. Xiang R.H., Hensel C.H., Garcia D.K., Carlson H.C., Kok K., Daly M.C., Kerbacher K., van den Berg A., Veldhuis P., Buys C.H., Naylor S.L. 1996. Isolation of the human semaphorin III/F gene (SEMA3F) at chromosome 3p21, a region deleted in lung cancer. Genomics. 32, 39-48.
79. Roche J., Boldog F., Robinson M., Robinson L., Varella-Garcia M., Swanton M., Waggoner B., Fishel R., Franklin W., Gemmill R., Drabkin H. 1996. Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin. Oncogene. 12, 1289-1297.
80. Tomizawa Y., Sekido Y., Kondo M., Gao B., Yokota J., Roche J., Drabkin H., Lerman M.I., Gazdar A.F., Minna J.D. 2001. Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B. Proc. Natl. Acad. Sci. USA. 98, 13954-13959.
81. Todd M.C., Xiang R.H., Garcia D.K., Kerbacher K.E., Moore S.L., Hensel C.H., Liu P., Siciliano M.J., Kok K., van den Berg A., Veldhuis P., Buys C.H., Killary A.M., Naylor S.L. 1996. An 80 Kb P1 clone from chromosome 3p21.3 suppresses tumor growth in vivo. Oncogene. 13, 2387-2396.
82. Tse C., Xiang R.H., Bracht T., Naylor S.L. 2002. Human Semaphorin 3B (SEMA3B) located at chromosome 3p21.3 suppresses tumor formation in an adenocarcinoma cell line. Cancer Res. 62, 542-546.
83. Xiang R., Davalos A.R., Hensel C.H., Zhou X.J., Tse C., Naylor S.L. 2002. Semaphorin 3F gene from human 3p21.3 suppresses tumor formation in nude mice. Cancer Res. 62, 2637-2643.
84. Bateman A., Birney E., Durbin R., Eddy S.R., Finn R.D., Sonnhammer E.L. 1999. Pfam 3.1: 1313 multiple alignments and profile HMMs match the majority of proteins. Nucleic Acids Res. 27, 260-262.
85. Trusolino L., Comoglio P.M. 2002. Scatter-factor and semaphorin receptors: cell signalling for invasive growth. Nature Rev. Cancer. 2, 289-300.
86. Fujisawa H., Kitsukawa T. 1998. Receptors for collapsin/semaphorins. Current Opin. Neurobiol. 8, 587-592.
87. Keith R.L., Miller Y.E., Gemmill R.M., Drabkin H.A., Dempsey E.C., Kennedy T.C., Prindiville S., Franklin W.A. 2000. Angiogenic squamous dysplasia in bronchi of individuals at high risk for lung cancer. Clin. Cancer Res. 6, 1616-1625.
88. Brambilla E., Constantin B., Drabkin H., Roche J. 2000. Semaphorin SEMA3F localization in malignant human lung and cell lines: A suggested role in cell adhesion and cell migration. Am. J. Pathol. 156, 939-950.
89. Ji L., Nishizaki M., Gao B., Burbee D., Kondo M., Kamibayashi C., Xu K., Yen N., Atkinson E.N., Fang B., Lerman M.I., Roth J.A., Minna J.D. 2002. Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo. Cancer Res. 62, 2715-2720.
90. Frederick A., Rolfe M., Chiu M.I. 1998. The human UNP locus at 3p21.31 encodes two tissue-selective, cytoplasmic isoforms with deubiquitinating activity that have reduced expression in small cell lung carcinoma cell lines. Oncogene. 16, 153-165.
91. Lee K.K., Ohyama T., Yajima N., Tsubuki S., Yonehara S. 2001. MST, a physiological caspase substrate, highly sensitizes apoptosis both upstream and downstream of caspase activation. J. Biol. Chem. 276, 19276-19285.
92. Protopopov A., Kashuba V.I., Zabarovska V.I., Muravenko O. V., Lerman M.I., Klein G., Zabarovsky E.R. 2003. An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies. Cancer Res. 63 (in press).
93. Daigo Y., Nishiwaki T., Kawasoe T., Tamari M., Tsuchiya E., Nakamura Y. 1999. Molecular cloning of a candidate tumor suppressor gene, DLC1, from chromosome 3p21.3. Cancer Res.. 59, 1966-1972.
94. Maruyama R., Toyooka S., Toyooka K.O., Virmani A.K., Zochbauer-Muller S., Farinas A.J., Minna J.D., McConnell J., Frenkel E.P., Gazdar A.F 2002. Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features. Clin. Cancer Res. 8, 514-519.
95. Toulouse A., Morin J., Dion P.A., Houle B., Bradley W.E. 2000. RARbeta2 specificity in mediating RA inhibition of growth of lung cancer-derived cells. Lung Cancer. 28, 127-137.
96. Pfeifer G.P., Yoon J.-H., Liu L., Tommasi S., Wilczynski Sh.P., Dammann R. 2002. Methylation of the RASSF1A gene in human cancers. Biol. Chem. 383, 907-914.
97. Dammann R., Takahashi T., Pfeifer G.P. 2001. The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas. Oncogene. 20, 3563-3567.
98. Zochbauer-Muller S., Fong K.M., Virmani A.K., Geradts J., Gazdar A.F., Minna J.D. 2001. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res. 61, 249-255.
99. Zochbauer-Muller S., Fong K.M., Maitra A., Lam S., Geradts J., Ashfaq R., Virmani A.K., Milchgrub S., Gazdar A.F., Minna J.D. 2001. 5′ CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer. Cancer Res. 61, 3581-3585.
100. Palmisano W.A., Divine K.K., Saccomanno G., Gilliland F.D., Baylin S.B., Herman J.G., Belinsky S.A. 2000. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res. 60, 5954-5958.
101. Wong I.H.N., Lo Y.M.D., Zhang J., Liew Ch.-T., Ng M.H.L., Wong N., Lai P.B.S., Lau W.Y., Hjelm N.M., Johnson Ph.J. 1999. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res. 59, 71-73.
102. Silva J.M., Dominguez G., Villanueva M.J., Gonzalez R., Garcia J.M., Corbacho C., Provencio M., Espana P., Bonilla F. 1999. Aberrant DNA methylation of the p16-INK4a gene in plasma DNA of breast cancer patients. British J. Cancer. 80, 1262-1264.
103. Tomizawa Y., Kohno T., Kondo H., Otsuka A., Nishioka M., Niki T., Yamada T., Maeshima A., Yoshimura K., Saito R., Minna J.D., Yokota J. 2002. Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21. 3 in stage I lung adenocarcinoma. Clin. Cancer Res. 8, 2362-2368.